• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Monday

    8/15/22 11:36:10 AM ET
    $API
    $BFRI
    $DNAA
    $EAST
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $API alert in real time by email

     

    On Monday, 31 companies hit new 52-week lows.

    Noteworthy Mentions In Today's 52-Week Lows:

    • The largest company in terms of market cap to set a new 52-week low was PetroChina Co (NYSE:PTR).
    • SciSparc (NASDAQ:SPRC) is the smallest company on a market cap basis to set a new 52-week low.
    • Nocera (NASDAQ:NCRA)'s stock dropped the most, trading down 15.92% to reach a new 52-week low.
    • Orion Energy Sys (NASDAQ:OESX)'s shares had the biggest turnaround, impressively rebounding 0.3% after reaching a new 52-week low.

    Stocks dropping to new 52-week lows on Monday:

    • GSK (NYSE:GSK) shares were down 4.07% for the day, having made a 52-week low of $34.43.
    • TTEC Holdings (NASDAQ:TTEC) shares set a new yearly low of $57.66 this morning. The stock was up 0.51% on the session.
    • SmartRent (NYSE:SMRT) shares were down 11.78% for the day, having made a 52-week low of $3.35.
    • Maverix Metals (AMEX:MMX) stock drifted down 3.79% on Monday morning to hit a new 52-week low of $3.80.
    • Agora (NASDAQ:API) shares hit a yearly low of $4.60. The stock was down 1.48% on the session.
    • Starry Group Holdings (NYSE:STRY) shares were down 2.58% for the day, having made a 52-week low of $2.66.
    • HomeTrust Bancshares (NASDAQ:HTBI) shares were down 0.89% for the day, having made a 52-week low of $22.86.
    • Social Cap Suvretta Hldgs (NASDAQ:DNAA) stock achieved a new 52-week low on Monday morning, hitting $9.48 and moving down 3.21%.
    • CorpHousing Group (NASDAQ:CHG) stock broke to a new 52-week low of $2.88 on Monday. Shares of the company traded down 14.05%.
    • Wag Group (NASDAQ:PET) shares moved down 4.78% on Monday to hit a new 52-week low of $7.12, drifting down 4.78%.
    • Inspirato (NASDAQ:ISPO) stock drifted down 6.17% on Monday morning to hit a new 52-week low of $3.68.
    • POET Technologies (NASDAQ:POET) stock hit a new 52-week low of $3.03. The stock was down 9.96% on the session.
    • Sierra Metals (AMEX:SMTS) stock set a new 52-week low of $0.51 on Monday, moving down 8.5%.
    • Forza X1 (NASDAQ:FRZA) shares set a new yearly low of $5.81 this morning. The stock was down 11.35% on the session.
    • Loyalty Ventures (NASDAQ:LYLT) stock broke to a new 52-week low of $2.56 on Monday. Shares of the company traded down 6.5%.
    • Orion Energy Sys (NASDAQ:OESX) shares fell to $1.63 on Monday, setting a new 52-week low with a shift of down 0.3%.
    • PLx Pharma (NASDAQ:PLXP) shares moved down 15.43% on Monday to hit a new 52-week low of $1.33, drifting down 15.43%.
    • IN8bio (NASDAQ:INAB) stock set a new 52-week low of $1.84 on Monday, moving up 1.62%.
    • Biofrontera (NASDAQ:BFRI) stock hit a new 52-week low of $1.30. The stock was down 6.38% on the session.
    • Nocera (NASDAQ:NCRA) stock set a new 52-week low of $2.00 on Monday, moving down 15.92%.
    • Eastside Distilling (NASDAQ:EAST) shares hit a yearly low of $0.52. The stock was down 12.46% on the session.
    • SciSparc (NASDAQ:SPRC) shares fell to $1.02 on Monday, setting a new 52-week low with a shift of down 6.24%.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $API alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $API
    $BFRI
    $DNAA
    $EAST

    CompanyDatePrice TargetRatingAnalyst
    GSK plc
    $GSK
    6/3/2025Buy → Hold
    Berenberg
    GSK plc
    $GSK
    4/15/2025$35.25Neutral
    Exane BNP Paribas
    GSK plc
    $GSK
    2/12/2025Equal-Weight
    Morgan Stanley
    Agora Inc.
    $API
    1/16/2025$6.00Neutral → Buy
    BofA Securities
    POET Technologies Inc.
    $POET
    11/18/2024$6.00Outperform
    Northland Capital
    GSK plc
    $GSK
    11/15/2024Buy → Hold
    Deutsche Bank
    Wag! Group Co.
    $PET
    11/14/2024Buy → Hold
    Craig Hallum
    GSK plc
    $GSK
    11/12/2024$53.00 → $39.50Buy → Hold
    Jefferies
    More analyst ratings

    $API
    $BFRI
    $DNAA
    $EAST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GlaxoSmithKline downgraded by Berenberg

    Berenberg downgraded GlaxoSmithKline from Buy to Hold

    6/3/25 7:26:51 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Exane BNP Paribas initiated coverage on GlaxoSmithKline with a new price target

    Exane BNP Paribas initiated coverage of GlaxoSmithKline with a rating of Neutral and set a new price target of $35.25

    4/15/25 12:40:46 PM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Morgan Stanley initiated coverage on GlaxoSmithKline

    Morgan Stanley initiated coverage of GlaxoSmithKline with a rating of Equal-Weight

    2/12/25 7:05:11 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $API
    $BFRI
    $DNAA
    $EAST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CFO Stemm Daryl converted options into 834 shares and covered exercise/tax liability with 350 shares, increasing direct ownership by 0.59% to 83,102 units (SEC Form 4)

    4 - SmartRent, Inc. (0001837014) (Issuer)

    10/20/25 4:24:40 PM ET
    $SMRT
    EDP Services
    Technology

    Chief Technology Officer Derose-Wilson Isaiah converted options into 1,111 shares and covered exercise/tax liability with 465 shares, increasing direct ownership by 0.58% to 112,815 units (SEC Form 4)

    4 - SmartRent, Inc. (0001837014) (Issuer)

    10/20/25 4:24:53 PM ET
    $SMRT
    EDP Services
    Technology

    CEO, TTEC DIGITAL Seybold David J. converted options into 21,477 shares and covered exercise/tax liability with 6,465 shares, increasing direct ownership by 59% to 40,527 units (SEC Form 4)

    4 - TTEC Holdings, Inc. (0001013880) (Issuer)

    10/6/25 4:30:11 PM ET
    $TTEC
    Professional Services
    Consumer Discretionary

    $API
    $BFRI
    $DNAA
    $EAST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Inspirato Introduces Luxury Catamaran Charters

    DENVER, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Inspirato Incorporated ("Inspirato" or the "Company") (NASDAQ:ISPO), the premier luxury vacation club and property technology company, announces an expansion of its Inspirato Bespoke offerings with access to a curated collection of world-class catamarans available for private charter. The addition enhances member opportunities to experience private sailing adventures across the Caribbean, including the U.S. Virgin Islands and British Virgin Islands.  Each vessel in the collection has been meticulously vetted to meet Inspirato's standards for design, comfort, and service. Guests can craft personalized itineraries that blend modern luxury with the

    10/29/25 9:00:00 AM ET
    $ISPO
    Blank Checks
    Finance

    IN8bio Expands INB-100 Phase 1 Clinical Trial with Addition of The Ohio State University as New Site

    NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (NASDAQ:INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune diseases, today announced that The Ohio State University has been added as a new clinical site in the ongoing Phase 1 trial of the Company's INB-100, a donor-derived allogeneic gamma-delta T cell therapy for patients with leukemias undergoing haploidentical stem cell transplantation. The addition of this leading academic institution reflects a strong interest in INB-100 and supports the ongoing efforts to accelerate enrollment and complete this Phase 1 trial. "This trial is an excellent opportunity

    10/29/25 8:00:00 AM ET
    $INAB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    POET Technologies Announces Closing of US$150 Million Oversubscribed Registered Direct Offering of Common Shares

    The offering was fully subscribed by two new fundamental investment managers. The Company's pro-forma cash position is in excess of US$300 million immediately following the closing. TORONTO, Oct. 28, 2025 (GLOBE NEWSWIRE) -- POET Technologies Inc. (NASDAQ:POET) (the "Company"), the designer and developer of the POET Optical Interposer™, Photonic Integrated Circuits (PICs) and light sources for the data center, tele-communication and artificial intelligence markets, today announced the closing of its previously announced registered direct offering of 20,689,655 common shares , resulting in gross proceeds of approximately US$150 million, before deducting offering expenses. The closing of th

    10/28/25 1:31:27 PM ET
    $POET
    Semiconductors
    Technology

    $API
    $BFRI
    $DNAA
    $EAST
    Leadership Updates

    Live Leadership Updates

    View All

    Pankaj Bansi Joins SmartRent as Chief Transformation Officer

    Strategic leader to drive operational excellence, scalability and support long-term growth SmartRent, Inc. (NYSE:SMRT) ("SmartRent" or the "Company"), the leading provider of smart communities and smart operations solutions for the rental housing industry, today announced the appointment of Pankaj Bansi as Chief Transformation Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251009224318/en/A proven business modernization leader with more than 30 years of experience at the intersection of real estate and technology, Bansi will lead SmartRent's enterprise transformation strategy. Over the course of his career, he has led

    10/9/25 3:30:00 PM ET
    $SMRT
    EDP Services
    Technology

    TTEC Digital and VoxEQ Partner to Deliver Real-Time Voice Biometrics in SmartApps Cloud

    The integration with TTEC Digital's proprietary SmartApps Cloud delivers cost-effective, AI-powered fraud prevention to organizations of all sizes AUSTIN, Texas, Sept. 8, 2025 /PRNewswire/ -- TTEC Holdings Inc. (NASDAQ:TTEC) a leading global CX (customer experience) technology and services innovator for AI-enabled CX, today announced a new partnership between TTEC Digital and VoxEQ. "Our partnership with VoxEQ is a game-changer for our SmartApps Cloud clients." - Dave Seybold, CEO, TTEC DigitalThis partnership brings voice biometrics and fraud prevention to SmartApps Cloud, TTEC Digital's proprietary software platform for financial services companies. The integration with VoxEQ marks a signi

    9/8/25 9:25:00 AM ET
    $TTEC
    Professional Services
    Consumer Discretionary

    Biofrontera Inc. Appoints George Jones as Chief Commercial Officer

    Woburn, MA, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company focused on the development and commercialization of photodynamic therapy (PDT), today announced the appointment of George Jones as Chief Commercial Officer (CCO), starting August 25, 2025. In this role, Mr. Jones will oversee the Company's commercial functions, including sales, marketing, and market access. He will report directly to CEO Dr. Hermann Luebbert. This strengthening of the Company's management follows the recent announcement of an agreement to acquire all rights and assets related to Ameluz® and RhodoLED® for the US market, including the FDA approval and al

    8/11/25 4:25:00 PM ET
    $BFRI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $API
    $BFRI
    $DNAA
    $EAST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Martell Frank bought $79,115 worth of shares (50,000 units at $1.58) (SEC Form 4)

    4 - SmartRent, Inc. (0001837014) (Issuer)

    9/16/25 5:11:32 PM ET
    $SMRT
    EDP Services
    Technology

    Chief Executive Officer Martell Frank bought $148,500 worth of shares (100,000 units at $1.49) (SEC Form 4)

    4 - SmartRent, Inc. (0001837014) (Issuer)

    9/15/25 4:16:26 PM ET
    $SMRT
    EDP Services
    Technology

    CHIEF EXECUTIVE OFFICER Zamani Payam bought $59,200 worth of Class A Common Stock (20,000 units at $2.96), increasing direct ownership by 2% to 1,170,000 units (SEC Form 4)

    4 - Inspirato Inc (0001820566) (Issuer)

    8/28/25 4:01:11 PM ET
    $ISPO
    Blank Checks
    Finance

    $API
    $BFRI
    $DNAA
    $EAST
    Financials

    Live finance-specific insights

    View All

    Biofrontera Inc. Closes Purchase of All Ameluz® and RhodoLED® US Assets from Biofrontera AG

    Biofrontera Inc. acquires full U.S. rights to Ameluz® and RhodoLED®, including New Drug Application and associated patents, from former parent Biofrontera AG.New earnout structure reduces payment rate to 12%–15% of U.S. net sales from 25%–35%.Closing releases final $2.5 million of $11 million financing led by existing investors Rosalind Advisors and AIGH Capital Management, which is expected to fund Biofrontera Inc. to profitability. WOBURN, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), today announced the closing of i

    10/23/25 8:45:00 AM ET
    $BFRI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    TTEC Schedules Third Quarter 2025 Earnings Release and Webcast of Investor Conference Call

    AUSTIN, Texas, Oct. 15, 2025 /PRNewswire/ -- TTEC Holdings, Inc. (NASDAQ:TTEC), a leading global CX (customer experience) technology and services innovator for AI-enabled CX solutions, announced today that TTEC will release its earnings results after market close on Thursday, November 6, 2025, when a press release will be issued. The Company will host a live webcast and conference call at 8:30 a.m. ET on Friday, November 7, 2025. You are invited to join a live webcast of the conference call by visiting the "Investors Relations" section of the TTEC website at www.ttec.com. If you are unable to participate during the live webcast, a replay will be available on the TTEC website. ABOUT TTECTTEC

    10/15/25 5:39:00 PM ET
    $TTEC
    Professional Services
    Consumer Discretionary

    SmartRent to Report Third Quarter 2025 Financial Results on November 5, 2025

    SmartRent, Inc. (NYSE:SMRT) ("SmartRent" or the "Company"), the leading provider of smart communities solutions and smart operations solutions for the rental housing industry, today announced it will release third quarter of financial year 2025 results and host a conference call on Wednesday, November 5, 2025. Third quarter 2025 financial results will be released before the market opens, and at 11:30 a.m. ET, Frank Martell, the Company's President and Chief Executive Officer, and Daryl Stemm, Chief Financial Officer, will host a conference call and webcast to discuss the Company's performance. The press release and supporting materials will be available in the Events and Presentations secti

    10/15/25 4:05:00 PM ET
    $SMRT
    EDP Services
    Technology

    $API
    $BFRI
    $DNAA
    $EAST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Biofrontera Inc.

    SC 13G/A - Biofrontera Inc. (0001858685) (Subject)

    11/14/24 3:54:03 PM ET
    $BFRI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Biofrontera Inc.

    SC 13G/A - Biofrontera Inc. (0001858685) (Subject)

    11/14/24 1:13:39 PM ET
    $BFRI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Biofrontera Inc.

    SC 13G/A - Biofrontera Inc. (0001858685) (Subject)

    11/13/24 2:12:35 PM ET
    $BFRI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $API
    $BFRI
    $DNAA
    $EAST
    SEC Filings

    View All

    SEC Form 6-K filed by GSK plc

    6-K - GSK plc (0001131399) (Filer)

    10/29/25 11:23:12 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by GSK plc

    6-K - GSK plc (0001131399) (Filer)

    10/29/25 11:13:49 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by POET Technologies Inc.

    6-K - POET TECHNOLOGIES INC. (0001437424) (Filer)

    10/28/25 4:53:32 PM ET
    $POET
    Semiconductors
    Technology